101 related articles for article (PubMed ID: 10754455)
1. Pharmacological effects of a specific leukotriene B(4) receptor antagonist (VML 295) on blood leukocytes, cutaneous inflammation and epidermal proliferation.
Seegers BA; Andriessen MP; van Hooijdonk CA; de Bakker ES; van Vlijmen-Willems IM; Parker GL; van Erp PE; van de Kerkhof PC
Skin Pharmacol Appl Skin Physiol; 2000; 13(2):75-85. PubMed ID: 10754455
[TBL] [Abstract][Full Text] [Related]
2. The regulation of CD11b integrin levels on human blood leukocytes and leukotriene B4-stimulated skin by a specific leukotriene B4 receptor antagonist (LY293111).
van Pelt JP; de Jong EM; van Erp PE; Mitchell MI; Marder P; Spaethe SM; van Hooijdonk CA; Kuijpers AL; van de Kerkhof PC
Biochem Pharmacol; 1997 Apr; 53(7):1005-12. PubMed ID: 9174114
[TBL] [Abstract][Full Text] [Related]
3. Investigation on a novel and specific leukotriene B4 receptor antagonist in the treatment of stable plaque psoriasis.
Van Pelt JP; De Jong EM; Seijger MM; Van Hooijdonk CA; De Bakker ES; Van Vlijmen IM; Parker GL; Van Erp PE; Van De Kerkhof PC
Br J Dermatol; 1998 Sep; 139(3):396-402. PubMed ID: 9767282
[TBL] [Abstract][Full Text] [Related]
4. The effects of LY293111Na, a leukotriene B4 receptor antagonist, on the pulmonary neutrophilia and CD11b expression caused by inhalation of a leukotriene B4 aerosol in rhesus monkeys.
Allen DL; Hoffman WP; Marder P; Matchett MR; Leiter PA; Abbott DL; Wolff RK
J Pharmacol Exp Ther; 1996 Apr; 277(1):341-9. PubMed ID: 8613940
[TBL] [Abstract][Full Text] [Related]
5. Modulation of leukotriene B4 receptor-1 expression by dexamethasone: potential mechanism for enhanced neutrophil survival.
Stankova J; Turcotte S; Harris J; Rola-Pleszczynski M
J Immunol; 2002 Apr; 168(7):3570-6. PubMed ID: 11907121
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo pharmacological characterization of BIIL 284, a novel and potent leukotriene B(4) receptor antagonist.
Birke FW; Meade CJ; Anderskewitz R; Speck GA; Jennewein HM
J Pharmacol Exp Ther; 2001 Apr; 297(1):458-66. PubMed ID: 11259574
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of ex vivo neutrophil activation by oral LY293111, a novel leukotriene B4 receptor antagonist.
Marder P; Spaethe SM; Froelich LL; Cerimele BJ; Petersen BH; Tanner T; Lucas RA
Br J Clin Pharmacol; 1996 Oct; 42(4):457-64. PubMed ID: 8904617
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and pharmacodynamics of the leukotriene B4 receptor antagonist CP-105,696 in man following single oral administration.
Liston TE; Conklyn MJ; Houser J; Wilner KD; Johnson A; Apseloff G; Whitacre C; Showell HJ
Br J Clin Pharmacol; 1998 Feb; 45(2):115-21. PubMed ID: 9491823
[TBL] [Abstract][Full Text] [Related]
9. VML 295 (LY-293111), a novel LTB4 antagonist, is not effective in the prevention of relapse in psoriasis.
Mommers JM; Van Rossum MM; Kooijmans-Otero ME; Parker GL; van de Kerkhof PC
Br J Dermatol; 2000 Feb; 142(2):259-66. PubMed ID: 10730758
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of leukotriene B4-induced CD11B/CD18 (Mac-1) expression by BIIL 284, a new long acting LTB4 receptor antagonist, in patients with rheumatoid arthritis.
Alten R; Gromnica-Ihle E; Pohl C; Emmerich J; Steffgen J; Roscher R; Sigmund R; Schmolke B; Steinmann G
Ann Rheum Dis; 2004 Feb; 63(2):170-6. PubMed ID: 14722206
[TBL] [Abstract][Full Text] [Related]
11. Human granulocyte CD11b expression as a pharmacodynamic biomarker of inflammation.
Davis HM; Carpenter DC; Stahl JM; Zhang W; Hynicka WP; Griswold DE
J Immunol Methods; 2000 Jun; 240(1-2):125-32. PubMed ID: 10854607
[TBL] [Abstract][Full Text] [Related]
12. A novel flow cytometric assay of human whole blood neutrophil and monocyte CD11b levels: upregulation by chemokines is related to receptor expression, comparison with neutrophil shape change, and effects of a chemokine receptor (CXCR2) antagonist.
Nicholson GC; Tennant RC; Carpenter DC; Sarau HM; Kon OM; Barnes PJ; Salmon M; Vessey RS; Tal-Singer R; Hansel TT
Pulm Pharmacol Ther; 2007; 20(1):52-9. PubMed ID: 16406722
[TBL] [Abstract][Full Text] [Related]
13. Reversal of human neutrophil survival by leukotriene B(4) receptor blockade and 5-lipoxygenase and 5-lipoxygenase activating protein inhibitors.
Lee E; Lindo T; Jackson N; Meng-Choong L; Reynolds P; Hill A; Haswell M; Jackson S; Kilfeather S
Am J Respir Crit Care Med; 1999 Dec; 160(6):2079-85. PubMed ID: 10588632
[TBL] [Abstract][Full Text] [Related]
14. Involvement of endogenous leukotriene B4 and platelet-activating factor in polymorphonuclear leucocyte recruitment to dermal inflammatory sites in rats.
Bélanger C; Elimam H; Lefebvre J; Borgeat P; Marleau S
Immunology; 2008 Jul; 124(3):295-303. PubMed ID: 18217950
[TBL] [Abstract][Full Text] [Related]
15. The inter-relation between inflammation and epidermal proliferation in normal skin following epicutaneous application of leukotriene-B4--an immunohistochemical study.
de Jong EM; van Erp PE; van Vlijmen IM; van de Kerkhof PC
Clin Exp Dermatol; 1992 Nov; 17(6):413-20. PubMed ID: 1336720
[TBL] [Abstract][Full Text] [Related]
16. Leukotriene B4-mediated release of antimicrobial peptides against cytomegalovirus is BLT1 dependent.
Gaudreault E; Gosselin J
Viral Immunol; 2007 Sep; 20(3):407-20. PubMed ID: 17931111
[TBL] [Abstract][Full Text] [Related]
17. Role of neutrophil elastase in LTB4-induced neutrophil transmigration in vivo assessed with a specific inhibitor and neutrophil elastase deficient mice.
Young RE; Voisin MB; Wang S; Dangerfield J; Nourshargh S
Br J Pharmacol; 2007 Jul; 151(5):628-37. PubMed ID: 17471175
[TBL] [Abstract][Full Text] [Related]
18. Effects of leukotriene B4 receptor antagonist, LY293111Na, on antigen-induced bronchial hyperresponsiveness and leukocyte infiltration in sensitized guinea pigs.
Asanuma F; Kuwabara K; Arimura A; Furue Y; Fleisch JH; Hori Y
Inflamm Res; 2001 Mar; 50(3):136-41. PubMed ID: 11339501
[TBL] [Abstract][Full Text] [Related]
19. Leukotriene B4 signaling through NF-kappaB-dependent BLT1 receptors on vascular smooth muscle cells in atherosclerosis and intimal hyperplasia.
Bäck M; Bu DX; Bränström R; Sheikine Y; Yan ZQ; Hansson GK
Proc Natl Acad Sci U S A; 2005 Nov; 102(48):17501-6. PubMed ID: 16293697
[TBL] [Abstract][Full Text] [Related]
20. Leukotriene B4 induces release of antimicrobial peptides in lungs of virally infected mice.
Gaudreault E; Gosselin J
J Immunol; 2008 May; 180(9):6211-21. PubMed ID: 18424743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
